Literature DB >> 8523069

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

L B Rorke1, R Packer, J Biegel.   

Abstract

Clinical and morphological features of an apparently unique, biologically aggressive central nervous system tumor in 32 infants and children are presented. This neoplasm is formed wholly or partly by rhabdoid cells, areas resembling typical primitive neuroectodermal tumor, and, less frequently, malignant mesenchymal and/or epithelial tissue. The tumor has been named atypical teratoid/rhabdoid tumor (ATT/RhT) and is regarded as a unique class of primary central nervous system (CNS) tumors. It occurs most commonly in infants less than two years of age, has often metastasized throughout the CNS at presentation, dose not respond to therapy and causes death less than a year after diagnosis. These tumors may occur in any CNS site but almost 60% are located in the cerebellum. The most common chromosomal abnormality involves chromosome 22.

Entities:  

Mesh:

Year:  1995        PMID: 8523069     DOI: 10.1007/bf01052653

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  47 in total

1.  Intraorbital rhabdoid tumour following bilateral retinoblastoma.

Authors:  N Walford; R Deferrai; R M Slater; J F Delemarre; K P Dingemans; M A Van den Bergh Weerman; P A Voute
Journal:  Histopathology       Date:  1992-02       Impact factor: 5.087

2.  Malignant rhabdoid tumor. A morphological and flow cytometric study.

Authors:  D Schmidt; I Leuschner; D Harms; E Sprenger; H J Schäfer
Journal:  Pathol Res Pract       Date:  1989-02       Impact factor: 3.250

3.  Malignant rhabdoid tumour of colon.

Authors:  A H Yang; W Y Chen; H Chiang
Journal:  Histopathology       Date:  1994-01       Impact factor: 5.087

4.  The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases.

Authors:  J M Bonnin; L J Rubinstein; N F Palmer; J B Beckwith
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

5.  Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.

Authors:  J E Haas; N F Palmer; A G Weinberg; J B Beckwith
Journal:  Hum Pathol       Date:  1981-07       Impact factor: 3.466

6.  Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity.

Authors:  S J Hunt; W D Anderson
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

7.  Primary congenital rhabdoid tumor of the brain with neoplastic hydranencephaly.

Authors:  M E Velasco; J A Brown; J Kini; E S Ruppert
Journal:  Childs Nerv Syst       Date:  1993-06       Impact factor: 1.475

8.  Malignant rhabdoid tumor of the heart in an infant.

Authors:  E J Small; G J Gordon; B B Dahms
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

9.  Malignant rhabdoid tumour of soft tissue. An ultrastructural and immunohistological study of a pelvic tumour.

Authors:  P A Dervan; S F Cahalane; P Kneafsey; A Mynes; K McAllister
Journal:  Histopathology       Date:  1987-02       Impact factor: 5.087

10.  Primary rhabdoid tumour of the brain.

Authors:  S M Jakate; H B Marsden; L Ingram
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more
  45 in total

Review 1.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 2.  Molecular genetics of pediatric central nervous system tumors.

Authors:  Nicole J Ullrich; Scott L Pomeroy
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

3.  Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors.

Authors:  Hemant Parmar; Cynthia Hawkins; Eric Bouffet; James Rutka; Manohar Shroff
Journal:  Pediatr Radiol       Date:  2005-12-08

4.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

5.  A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father.

Authors:  Ewa Izycka-Swieszewska; Maria Debiec-Rychter; Bartosz Wasag; Agnieszka Wozniak; Dariusz Gasecki; Katarzyna Plata-Nazar; Jacek Bartkowiak; Jerzy Lasota; Janusz Limon
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

6.  Atypical teratoid/rhabdoid tumors in adult patients: CT and MR imaging features.

Authors:  L Han; Y Qiu; C Xie; J Zhang; X Lv; W Xiong; W Wang; X Zhang; P Wu
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

7.  Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases.

Authors:  Yeşim Ertan; Murat Sezak; Tuncer Turhan; Mehmet Kantar; Yusuf Erşahin; Saffet Mutluer; Canan Vergin; Haldun Oniz; Taner Akalin
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

8.  Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.

Authors:  Samantha Gadd; Simone Treiger Sredni; Chiang-Ching Huang; Elizabeth J Perlman
Journal:  Lab Invest       Date:  2010-03-08       Impact factor: 5.662

9.  Malignant rhabdoid tumor of the kidney and spine in an infant.

Authors:  Sejun Park; Jae-Hee Seo; Jun Bum Park; Sungchan Park
Journal:  J Korean Neurosurg Soc       Date:  2014-01-31

10.  High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Theodore Nicolaides; Tarik Tihan; Biljana Horn; Jaclyn Biegel; Michael Prados; Anuradha Banerjee
Journal:  J Neurooncol       Date:  2009-11-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.